HOME >> BIOLOGY >> NEWS
Rare Tibetan antelope listed as endangered

The Bronx Zoo-based Wildlife Conservation Society (WCS) today applauded a decision today by the U.S. Fish and Wildlife Service to list the Tibetan antelope, also known as "chiru," as an endangered species. Through a series of expeditions to China's windswept Chang Tang Reserve over the past two decades, WCS had played a key role in sounding the alarm about the dramatic decline of this elegant animal due to poaching.

The antelope's wool, considered the finest in the world, is used for "shahtoosh" shawls (shahtoosh translates to "king of wool"), which are sold in the black market for up to $15,000 each. In the 1980s and 1990s, smuggled shawls made their way to European and U.S. markets, and became elite though highly illegal fashion statements. With such a high price on its head, tens of thousands of antelope have been slaughtered in recent years.

The U.S. Fish and Wildlife Service is listing the Tibetan antelope under the Endangered Species Act, reinforcing protection for an animal already safeguarded under the Convention on International Trade in Endangered Species (CITES), which means that the species, including its parts and products, is prohibited from international trade for commercial purposes. The listing, published in today's Federal Register, takes effect April 28, 2006.

"With today's listing, the United States has made a real commitment to helping ensure the future of this beautiful species," said Dr. George Schaller of the Wildlife Conservation Society. "We commend the U.S. Fish and Wildlife Service for its decision to provide even more protection to the Tibetan antelope through the Endangered Species Act, one of this country's most important environmental laws."

Working with Chinese biologists, Dr. Schaller was the first western scientists to document the biology of the chiru, which lives in the isolated Tibetan plateau in China.

An upcoming National Geographic film will chronicle the plight of the chir
'"/>


30-Mar-2006


Page: 1 2

Related biology news :

1. Tibetan antelope slowly recovering, WCS says
2. Asias odd-ball antelope gets collared
3. HIV protein enlisted to help kill cancer cells
4. Scientists find endangered grey-shanked doucs in Vietnam
5. Legal ruling may put endangered species in danger
6. Update on census of wrlds most endangered cat -- female Amur leopard found dead
7. Saving endangered whales at no cost
8. Climate change has surprising effect on endangered naked carp
9. A human taste for rarity spells disaster for endangered species
10. Cambodia moves to protect endangered bird
11. Race to halt global amphibian crisis boosted by rediscovery of endangered Colombian frogs

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rare Tibetan antelope listed endangered

(Date:8/19/2015)...  VOXX International Corporation (Nasdaq: VOXX ) ... Definitive Agreement to purchase the assets, inclusive of ... EyeLock through an acquiring entity.  Upon consummation of ... in the acquiring entity. The closing of the ...  Expanding on its existing supply chain and distribution ...
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
(Date:8/12/2015)... Aug. 12, 2015   MedNet Solutions , an ... spectrum of clinical research, is proud to announce that ... comprehensive SaaS-based eClinical technology platform, has led the way ... two quarters of 2015.   Q2 2015 and Q1 ... measured by contract value sold in the company,s 15 ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2MedNet Solutions Experiences Explosive Corporate Growth 2
(Date:9/2/2015)... -- Biovista Inc. is glad to announce ... science challenge, a global competition hosted by the Rare ... the latest life science innovations and technologies. ... capability to support Steven Laffoon and his ... Niemann-Pick Disease Type A (NPA), a rare and fatal ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... -- Aytu BioScience, Inc. (OTCQB: AYTU), a specialty healthcare ... conditions, announced today that it has closed the final ... raising a total of $5.175 million, which includes proceeds ... Josh Disbrow , Chief Executive Officer of ... to be used to conduct clinical studies for both ...
(Date:9/2/2015)... , September 2, 2015 ... ("BioLight" or the "Company"), a firm that invests ... and cancer diagnostics, announced today that presentations highlighting ... will be delivered at the Ophthalmology Futures European ... Society of Cataract & Refractive Surgeons ("ESCRS"), both ...
Breaking Biology Technology:Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3
Cached News: